716
Views
17
CrossRef citations to date
0
Altmetric
Review

Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?

&
Pages 335-350 | Received 19 Dec 2015, Accepted 13 Jan 2016, Published online: 06 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Antonia Rotolo, Anastasios Karadimitris & Marco Ruella. (2018) Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies. Leukemia & Lymphoma 59:9, pages 2040-2055.
Read now
Roland B. Walter. (2018) Investigational CD33-targeted therapeutics for acute myeloid leukemia. Expert Opinion on Investigational Drugs 27:4, pages 339-348.
Read now
Naval Daver, Jorge Cortes, Hagop Kantarjian & Farhad Ravandi. (2016) Acute myeloid leukemia: advancing clinical trials and promising therapeutics. Expert Review of Hematology 9:5, pages 433-445.
Read now

Articles from other publishers (14)

Grégory Ehx, Jean-David Larouche, Chantal Durette, Jean-Philippe Laverdure, Leslie Hesnard, Krystel Vincent, Marie-Pierre Hardy, Catherine Thériault, Caroline Rulleau, Joël Lanoix, Eric Bonneil, Albert Feghaly, Anca Apavaloaei, Nandita Noronha, Céline M. Laumont, Jean-Sébastien Delisle, Luca Vago, Josée Hébert, Guy Sauvageau, Sébastien Lemieux, Pierre Thibault & Claude Perreault. (2021) Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes. Immunity 54:4, pages 737-752.e10.
Crossref
Naveen Pemmaraju, Natalie C. Chen & Srdan Verstovsek. (2021) Immunotherapy and Immunomodulation in Myeloproliferative Neoplasms. Hematology/Oncology Clinics of North America 35:2, pages 409-429.
Crossref
Mehrdad Mahalleh, Mahsima Shabani, Elham Rayzan & Nima Rezaei. (2019) Reinforcing the primary immunotherapy modulators against acute leukemia; monoclonal antibodies in AML. Immunotherapy 11:18, pages 1583-1600.
Crossref
Michele Stanchina, Alessandro Pastore, Sean Devlin, Christopher Famulare, Eytan Stein & Justin Taylor. (2019) CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A. Journal of Hematology & Oncology 12:1.
Crossref
Yimin ShiLillia Dincheva-VogelCharles E. AyemobaJeffrey P. FungCristina Bergamaschi, George N. Pavlakis, Farzin Farzaneh & Karin M. L. Gaensler. (2018) IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice. Blood Advances 2:22, pages 3177-3192.
Crossref
Nicola Gökbuget, Jonathan Canaani, Arnon Nagler, Michael Bishop, Nicolaus Kröger & David Avigan. (2018) Prevention and treatment of relapse after stem cell transplantation with immunotherapy. Bone Marrow Transplantation 53:6, pages 664-672.
Crossref
Armin Rashidi, Daniel J. Weisdorf & Nelli Bejanyan. (2018) Treatment of relapsed/refractory acute myeloid leukaemia in adults. British Journal of Haematology 181:1, pages 27-37.
Crossref
Elisabeth Paietta. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 237 279 .
Kristen Pettit & Olatoyosi Odenike. (2017) Novel Therapies for Myelofibrosis. Current Hematologic Malignancy Reports 12:6, pages 611-624.
Crossref
Stephen Sze-Yuen Lam, Alex Bai-Liang He & Anskar Yu-Hung Leung. (2017) Treatment of acute myeloid leukemia in the next decade – Towards real-time functional testing and personalized medicine. Blood Reviews 31:6, pages 418-425.
Crossref
John Anderson. (2017) Unleashing the immune response against childhood solid cancers. Pediatric Blood & Cancer 64:10, pages e26548.
Crossref
N Khan, R K Hills, P Virgo, S Couzens, N Clark, A Gilkes, P Richardson, S Knapper, D Grimwade, N H Russell, A K Burnett & S D Freeman. (2016) Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia. Leukemia 31:5, pages 1059-1068.
Crossref
Geórgia Muccillo Dexheimer, Jayse Alves, Laura Reckziegel, Gabrielle Lazzaretti & Ana Lucia Abujamra. (2017) DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome. Disease Markers 2017, pages 1-14.
Crossref
Jitka FucikovaIva TruxovaMichal HenslerEtienne BechtLenka KasikovaIrena MoserovaSarka VosahlikovaJana KlouckovaSarah E. ChurchIsabelle CremerOliver KeppGuido KroemerLorenzo GalluzziCyril Salek & Radek Spisek. (2016) Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood 128:26, pages 3113-3124.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.